Preconditioning effects on expression of proto-oncogenes c-fos and c-jun after hepatic ischemia/reperfusion in rats

Hepatobiliary and Pancreatic Diseases International

Volumn 4, Issue 2, 2005, Pages 197-202

  Xiao, Jian Sheng ^a   Cai, Fang Gang ^b   Niu, Ying ^a   Zhang, Yi ^a   Xu, Xian Ling ^a   Ye, Qi Fa ^c  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b Fujian Medical College   (China)

^c CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

C fos; C jun; Immediate early genes; Ischemic preconditioning; Liver

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; KI 67 ANTIGEN; MESSENGER RNA; PROTEIN C FOS; PROTEIN C JUN;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN DETECTION; APOPTOSIS; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CELL REGENERATION; CONTROLLED STUDY; FLOW CYTOMETRY; GENE EXPRESSION; GENETIC TRANSCRIPTION; HISTOPATHOLOGY; IMMEDIATE EARLY GENE; LIVER ISCHEMIA; LIVER PROTECTION; MALE; NONHUMAN; PROTEIN FUNCTION; PROTO ONCOGENE; RAT; RAT STRAIN; REPERFUSION INJURY;

ANIMALS; BASE SEQUENCE; BIOLOGICAL MARKERS; BIOPSY, NEEDLE; DISEASE MODELS, ANIMAL; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; ISCHEMIA; ISCHEMIC PRECONDITIONING; LIVER; LIVER FUNCTION TESTS; MALE; MOLECULAR SEQUENCE DATA; PROBABILITY; PROTO-ONCOGENE PROTEINS C-FOS; PROTO-ONCOGENE PROTEINS C-JUN; RANDOM ALLOCATION; RATS; RATS, WISTAR; REPERFUSION INJURY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RISK FACTORS; RNA, MESSENGER; SENSITIVITY AND SPECIFICITY;

EID: 20344389021     PISSN: 14993872     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Teoh NC, Farrell GC. Hepatic ischemia reperfusion injury: Pathogenic mechanisms and basis for hepatoprotection. J Gastroenterol Hepatol 2003;18:891-902.
2. Selzner N, Rudiger H, Graf R, Clavien PA. Protective strategies against ischemic injury of the liver. Gastroenterology 2003; 125:917-936.
3. Arii S, Teramoto K, Kawamura T. Current progress in the understanding of and therapeutic strategies for ischemia and reperfusion injury of the liver. J Hepatobiliary Pancreat Surg 2003; 10:189-194.
4. Zhang SJ, Zhu CJ, Zhao YF, Li J, Guo WZ. Different ischemic preconditioning for rat liver graft: protection and mechanism. Hepatobiliary Pancreat Dis Int 2003;2:509-512.
5. Ricciardi R, Schaffer BK, Kim RD, Shah SA, Donohue SE, Wheeler SM, et al. Protective effects of ischemic preconditioning on the cold-preserved liver are tyrosine kinase dependent. Transplantation 2001;72:406-412.
6. Ishii S, Abe T, Saito T, Tsuchiya T, Kanno H, Miyazawa M, et al. Effects of preconditioning on ischemia/reperfusion injury of hepatocytes determined by immediate early gene transcription. J Hepatobiliary Pancreat Surg 2001;8:461-468.
7. Itoh H, Yagi M, Hasebe K, Fushida S, Tani T, Hashimoto T, et al. Activation of immediate early gene c-fos and c-jun in the rat small intestine after ischemia/reperfusion. Transplantation 2000;69:598-604.
8. Taguchi T, Shima Y, Nakao M, Fujii Y, Tajiri T, Ogita K, et al. Activation of immediate early genes in relation to proliferation and apoptosis of enterocytes after ischemia-reperfusion injury of small intestine. Transplantation Proc 2002;34:938.
9. Ohmori M, Miyashita F, Uchida H, Kitoh Y, Tsuruoka S, Harada K, et al. Effect of erythromycin on ischemia-reperfusion injury of liver in rats. Transplant Proc 2000;32:811-814.
10. Chouker A, Martignoni A, Schauer R, Dugas M, Rau HG, Jauch KW, et al. Beneficial effects of ischemic preconditioning in patients undergoing hepatectomy: the role of neutrophils. Arch Surg 2005;140:129-136.
11. Koti RS, Yang W, Glantzounis G, Quaglia A, Davidson BR, Seifalian AM. Effect of ischaemic preconditioning on hepatic oxygenation, microcirculation and function in a rat model of moderate hepatic steatosis. Clin Sci (Lond) 2005;108:55-63.
12. Vajdova K, Heinrich S, Tian Y, Graf R, Clavien PA. Ischemic preconditioning and intermittent clamping improve murine hepatic microcirculation and Kupffer cell function after ischemic injury. Liver Transpl 2004;10:520-528.
13. Peralta C, Bartrons R, Riera L, Manzano A, Xaus C, Gelpi E, et al. Hepatic preconditioning preserves energy metabolism during sustained ischemia. Am J Physiol 2000;279: G163-171.
14. Carini R, Albano E. Recent insights on the mechanisms of liver preconditioning. Gastroenterology 2003;125:1480-1491.
15. Tejima K, Arai M, Ikeda H, Tomiya T, Yanase M, Inoue Y, et al. Ischemic preconditioning protects hepatocytes via reactive oxygen species derived from Kupffer cells; in rats. Gastroenterology 2004; 127:1488-1496.
16. Yuan GJ, Ma JC, Gong ZJ, Sun XM, Zheng SH, Li X. Modulation of liver oxidant-antioxidant system by ischemic preconditioning during ischemia/reperfusion injury in rats. World J Gastroenterol 2005;11:1825-1828.
17. Wang LM, Tian XF, Song QY, Gao ZM, Luo FW, Yang CM. Expression and role of inducible nitric oxide synthase in ischemia-reperfusion liver in rats. Hepatobiliary Pancreat Dis Int 2003;2:252-258.
18. 2 receptors. Hepatology 1999;29:126-132.
19. Li SQ, Liang LJ, Huang JF, Li Z. Hepatocyte apoptosis induced by hepatic ischemia-reperfusion injury in cirrhotic rat. Hepatobiliary Pancreat Dis Int 2003;2:102-105.
20. Kohli V, Selzner M, Madden JF, Bentley RC, Clavien PA. Endothelial cell and hepatocyte deaths occur by apoptosis after ischemia-reperfusion injury in the rat liver. Transplantation 1999;67:1099-1105.
21. Kabelitz D. Apoptosis graft rejection and transplantation tolerance. Transplantation 1998;65:869-875.
22. Hai S, Takemura S, Minamiyama Y, Yamasaki K, Yamamoto S, Kodai S, et al. Mitochondrial K(ATP) channel opener prevents ischemia-reperfusion injury in rat liver. Transplant Proc 2005;37:428-431.
23. Riordan SM, Williams R. Acute liver failure: targeted artificial and hepatocyte based support of liver regeneration and reversed of multiorgan failure. Hepatology 2000;32(1 suppl):63-76.
24. Kanno H, Abe T, Saito T, Tsuchiya T, Miyazawa M, Suzuki M, et al. Induction of immediate early genes after partial hepatectomy in cholestatic liver. J Hepatobiliary Pancreat Surg 2001;8:259-267.
25. Wisdom R. AP-1: One switch for many signals. Exp Cell Res 1999;253:180-185.
26. Wisdom R, Johnson R, Moore C. c-jun regulates cell cycle progression and apoptosis by distinct mechanisms. EMBO J 1999;18:189-198.
27. Schlossberg H, Zhang Y, Dudus L, Engelhardt JF. Expression of c-fos and c-jun during hepatocellular remodeling following ischemia/reperfusion in mouse liver. Hepatology 1996; 23: 1546-1555.
28. Sharma SK, Chapman D, Temsah R, Netticadan T, Brasil DP, Dhalla NS. Prevention of vascular apoptosis in myocardial infarction by Losartan. J Cardiovasc Pharmacol Ther 1999;4: 77-84.
29. Saito T, Matsumoto I, Goto S, Kamada N, Motoki R, Wilce PA. The differential induction of two immediate early genes, c-fos and c-jun after systemic hypovolemic shock/resuscitation in the rat liver and kidney. Surg Today 1998;28:608-617.
30. Michalopoulos GK, Defrance MC. Liver regeneration. Science 1997;276:60-66.